drugset / Trial / NCT02089386

Tamoxifen to Treat Barrett's Metaplasia

NCT02089386

Phase 0 Terminated 7 enrolled Washington University School of Medicine
NaSingle-groupOpen-labelPrevention

Summary

Treat Barrett's esophagus (BE) patients with tamoxifen to Barrett's metaplasia as measured by changes in Barrett's esophagus appearance by endoscopy and histology as well as changes in SOX2 and CDX2.

Timeline

Start
2014-07-09
Primary completion
2016-06-21
Completion
2016-06-21

Drugs

EvaluationDrugModalityDoseRoute
Subject Tamoxifen Small molecule 20 mg

Indications